The incidences of lymphopenia <1 × 109) in groups 2 and 3 were 58,3% (7/12) and 71.4% (15/21), and VLs in lungs were 18-1952 and 810-2657 SARS-CoV-2 cDNA copies per 100 ABL1, respectively. The gene discussed is ABL1; the disease is lymphopenia.